Department of Oncology, Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine, Changsha, 410006, P.R. China.
School of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410208, P.R. China.
BMC Gastroenterol. 2023 Jul 28;23(1):259. doi: 10.1186/s12876-023-02873-6.
N6A methylation (m6A) is a significant epigenetic modification that critically impacts post-transcriptional regulation and tumor occurrence and development. While previous studies have identified a role for epigenetic regulation in hepatocellular carcinoma (HCC), the potential function of the m6A cluster in Hepatitis B virus (HBV)-related HCC remains unclear.
The related information was downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). Based on the expression of 20 m6A regulators, we comprehensively evaluated the m6A clusters and systematically explored the correlation between these clusters and immune cell infiltration characteristics of the tumor microenvironment (TME). The patients were divided into low- and high-m6A score groups. Then, the immune cell infiltration, chemokines, and cytokines levels, and drug sensitivity were further explored between the two groups.
The m6A cluster predicted a better prognosis that was accompanied by increased immune cell infiltration. Using these results, an m6A score was established that could predict overall survival, immune checkpoints, and clinical treatments for patients with HBV-related HCC. This study demonstrated that m6A modifications affected tumorigenesis, TME, and the prognosis of patients with HBV-related HCC.
A comprehensive assessment of m6A patterns could improve the current understanding of immune cell infiltration patterns and inform the development of individualized cancer treatments.
N6A 甲基化(m6A)是一种重要的表观遗传修饰,对转录后调控和肿瘤的发生发展具有重要影响。虽然先前的研究已经确定了表观遗传调控在肝细胞癌(HCC)中的作用,但 m6A 簇在乙型肝炎病毒(HBV)相关 HCC 中的潜在功能尚不清楚。
从癌症基因组图谱(TCGA)和基因表达综合数据库(GEO)下载相关信息。基于 20 个 m6A 调节剂的表达,我们全面评估了 m6A 簇,并系统地探讨了这些簇与肿瘤微环境(TME)中免疫细胞浸润特征之间的相关性。患者被分为低 m6A 评分组和高 m6A 评分组。然后,进一步探讨两组间免疫细胞浸润、趋化因子和细胞因子水平以及药物敏感性。
m6A 簇预测预后较好,伴有免疫细胞浸润增加。利用这些结果,建立了一个 m6A 评分,可以预测 HBV 相关 HCC 患者的总生存率、免疫检查点和临床治疗。本研究表明,m6A 修饰影响 HBV 相关 HCC 的肿瘤发生、TME 和患者预后。
全面评估 m6A 模式可以提高对免疫细胞浸润模式的现有认识,并为个体化癌症治疗的发展提供信息。